We explore
SYMATESE LAB R&D department is fully integrated from design to production, including regulatory support.
Every year, our innovative medical devices, are used by specialized practitioners. Products which are created and developed, are manufactured in house.
Integrated innovation process
SYMATESE LAB’s Research and Development department is experienced and skilled to handle the design of new products with creativity and efficiency in an adapted and controlled quality environment.
Its offer is fully integrated from design to production and regulatory support.
SYMATESE’s experience in biopolymer transformation and medical device design, combined with its agility, allow for an optimized cost and time to market.
The partnership is managed by a tailor-made contract covering the relation from the design to the production phase to secure the partnership on the long run. We dedicate more than 10 % of our turnover to Research and Development every year in order to develop new and innovative MetTech solutions.
R&D Team
The Research and Development team is a strong multidisciplinary team of experienced doctors, engineers and technicians from different science disciplines such as chemistry, biochemistry, biomaterials, biology, and pharmacy. It comprises more than 25 people, and is internally supported by an analytical laboratory and an industrialisation team.
The R&D team matches biopolymer and plastic injection science with their medical application to design efficient and innovative medical devices. The team works in close collaboration with surgeons, physicians and practitioners to develop innovative products meeting the needs of both the user and patients.
Intellectual Property Policy
Acquisition and maintenance of effective IP rights is a key objective for R&D.
- IP strategy is fully integrated in SYMATESE LAB’s approach for design & development allowing SYMATESE LAB to own a consistent and wide IP portfolio,
- SYMATESE LAB possesses trademarks for its own products,
- SYMATESE LAB is also deeply involved in worldwide patent strategy development for innovative products and process protection.
In early development stages, SYMATESE LAB carries out research and state of the art analysis to provide a clarified view of patent opportunity and freedom to operate (FTO). Once opportunity is identified, a patent is written and filed. SYMATESE LAB currently owns nine patent families.
R&D Connections
Internally, it is SYMATESE LAB’s policy to involve regulatory affairs, production and marketing, from the early phase of development and through the entire development process.
The development of public and private partnerships allows SYMATESE LAB to offer ever more innovative solutions.
SYMATESE LAB is also involved in projects funded by the French National Agency for Research (ANR).
Accreditation
SYMATESE LAB is accredited by the French Ministry of Research and higher education as a research and development centre (CRO) for R&D Tax Credit.
